Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
12 mars 2024 16h05 HE
|
Clover Health Investments, Corp.
Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million...
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage
07 mars 2024 16h05 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., March 07, 2024 (GLOBE NEWSWIRE) -- Today Clover Health ("Clover" or "the Company") announced Clay Thornton as the newly appointed Chief Financial Officer of its Medicare Advantage...
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
26 févr. 2024 16h05 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth quarter...
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
16 févr. 2024 16h30 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) announced today that effective February 16, 2024, the Talent and...
Clover Health Provides Business Update and Full-Year 2024 Objectives
10 janv. 2024 08h30 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing...
PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
08 janv. 2024 17h00 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing...
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
21 déc. 2023 08h00 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) a physician enablement company committed to bringing access to great...
Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
18 déc. 2023 16h05 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing...
Clover Health Exits ACO REACH to Accelerate Path to Profitability
01 déc. 2023 08h15 HE
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing...
Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance
06 nov. 2023 16h05 HE
|
Clover Health Investments, Corp.
Q3 2023 Insurance MCR Improved to 78.5%, bringing year-to-date MCR to 80.8%, and Insurance revenue grew 12% compared to Q3 2022 Company reports Q3 2023 Net Loss of $41.5 million and Adjusted EBITDA...